Therapeutic Efficacy of Moxibustion with Seed-Sized Moxa-Cone at Jing Acupoint on Limb Spasticity after Stroke: A Meta-Analysis

ObjectiveTo systematically evaluate the effect of moxibustion with seed-sized moxa-cone at Jing acupoint on limb spasticity after stroke, and to provide a scientific basis for the clinical application of moxibustion with seed-sized moxa-cone.MethodsData were searched from the China Knowledge Network...

Full description

Saved in:
Bibliographic Details
Main Authors: ZHANG Jinfei, JIANG Jiahui, TANG Jiqin
Format: Article
Language:English
Published: Editorial Office of Rehabilitation Medicine 2023-08-01
Series:康复学报
Subjects:
Online Access:http://kfxb.publish.founderss.cn/thesisDetails#10.3724/SP.J.1329.2023.04011
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850123811346710528
author ZHANG Jinfei
JIANG Jiahui
TANG Jiqin
author_facet ZHANG Jinfei
JIANG Jiahui
TANG Jiqin
author_sort ZHANG Jinfei
collection DOAJ
description ObjectiveTo systematically evaluate the effect of moxibustion with seed-sized moxa-cone at Jing acupoint on limb spasticity after stroke, and to provide a scientific basis for the clinical application of moxibustion with seed-sized moxa-cone.MethodsData were searched from the China Knowledge Network (CNKI), Wanfang Data, VIP, CBMdisc, China Clinical Registry, PubMed, Embase, Web of Science and Cochrane Library. The randomized controlled trials (RCTs) of moxibustion with seed-sized moxa-cone at Jing acupoints for stroke patients with spastic hemiplegia were included, and the retrieval time was from inception to July 2022. The main outcome measures included the effective rate of spasticity improvement [number of cases (fully recovered + significant effect + some effect)/total number of cases]×100%], modified Ashworth scale (MAS) grading, clinical spasm index (CSI) score, Fugl-Meyer assessment scale (FMA) score, Barthel index (BI) score. Two researchers independently conducted literature screening according to the inclusion and exclusion criteria, data extraction, quality evaluation by the Cochrane risk of bias tool. RevMan 5.3 software was used for meta-analysis. Measurement data were expressed by mean difference (MD) and standardized mean difference (SMD) with 95% confidence interval (CI), and enumeration data were expressed by odds ratio (OR); SAS studio software was used to calculate the effect size (logrr) and standard error (selogrr) of ordinal data based on the cumulative odds model. The statistical heterogeneity was assessed by probability value (<italic>P</italic> value) and heterogeneity value (<italic>I</italic><sup>2</sup> value). If <italic>P</italic>≥0.1 and <italic>I</italic><sup>2</sup>≤50%, a fixed effects model would be used. If <italic>P</italic>&lt;0.1 or <italic>I</italic><sup>2</sup>&gt;50%, a random effects model would be used.ResultsA total of 10 RCTs with 736 patients were included, with 368 cases in the control group and the experimental group respectively. Meta-analysis results showed that, (1) The spasticity improvement rate: compared with the control group, the effective rate of the experimental group was significantly higher [<italic>OR</italic>=3.96, 95% <italic>CI</italic> (1.25,12.53), <italic>Z</italic>=2.34, <italic>P</italic>=0.02]. (2) MAS grade: compared with the control group, the grade of spasticity of the experimental group was significantly lower [<italic>RR</italic>=3.03, 95% <italic>CI</italic> (2.08, 4.41), <italic>Z</italic>=5.78, <italic>P</italic>&lt;0.000 01]. (3) CSI score: compared with the control group, CSI score of the experimental group was significantly lower [<italic>MD</italic>= -0.96, 95% <italic>CI</italic> (-1.26, -0.66), <italic>Z</italic>=6.20, <italic>P</italic>&lt;0.000 01]. (4) FMA score: compared with the control group, FMA score of the experimental group was significantly higher [<italic>MD</italic>=15.17, 95% <italic>CI</italic> (7.89, 22.46), <italic>Z</italic>=4.08, <italic>P</italic>&lt;0.000 1]. (5) BI score: compared with the control group, BI score of the experimental group was significantly higher [<italic>MD</italic>=5.95, 95% <italic>CI</italic> (4.38, 7.53), <italic>Z</italic>=7.39, <italic>P</italic>&lt;0.000 01].ConclusionMoxibustion with seed-sized moxa-cone at Jing acupoint can effectively improve the spasticity of limbs, reduce muscle tone, improve the motor function of limbs and quality of life of patients after stroke. However, more studies and samples would be needed for further validation in order to provide more reliable clinical evidence, due to the limitations of the included literature.
format Article
id doaj-art-012dd8b6017e438eabcdc21c2b69e9cc
institution OA Journals
issn 2096-0328
language English
publishDate 2023-08-01
publisher Editorial Office of Rehabilitation Medicine
record_format Article
series 康复学报
spelling doaj-art-012dd8b6017e438eabcdc21c2b69e9cc2025-08-20T02:34:31ZengEditorial Office of Rehabilitation Medicine康复学报2096-03282023-08-013335936641637702Therapeutic Efficacy of Moxibustion with Seed-Sized Moxa-Cone at Jing Acupoint on Limb Spasticity after Stroke: A Meta-AnalysisZHANG JinfeiJIANG JiahuiTANG JiqinObjectiveTo systematically evaluate the effect of moxibustion with seed-sized moxa-cone at Jing acupoint on limb spasticity after stroke, and to provide a scientific basis for the clinical application of moxibustion with seed-sized moxa-cone.MethodsData were searched from the China Knowledge Network (CNKI), Wanfang Data, VIP, CBMdisc, China Clinical Registry, PubMed, Embase, Web of Science and Cochrane Library. The randomized controlled trials (RCTs) of moxibustion with seed-sized moxa-cone at Jing acupoints for stroke patients with spastic hemiplegia were included, and the retrieval time was from inception to July 2022. The main outcome measures included the effective rate of spasticity improvement [number of cases (fully recovered + significant effect + some effect)/total number of cases]×100%], modified Ashworth scale (MAS) grading, clinical spasm index (CSI) score, Fugl-Meyer assessment scale (FMA) score, Barthel index (BI) score. Two researchers independently conducted literature screening according to the inclusion and exclusion criteria, data extraction, quality evaluation by the Cochrane risk of bias tool. RevMan 5.3 software was used for meta-analysis. Measurement data were expressed by mean difference (MD) and standardized mean difference (SMD) with 95% confidence interval (CI), and enumeration data were expressed by odds ratio (OR); SAS studio software was used to calculate the effect size (logrr) and standard error (selogrr) of ordinal data based on the cumulative odds model. The statistical heterogeneity was assessed by probability value (<italic>P</italic> value) and heterogeneity value (<italic>I</italic><sup>2</sup> value). If <italic>P</italic>≥0.1 and <italic>I</italic><sup>2</sup>≤50%, a fixed effects model would be used. If <italic>P</italic>&lt;0.1 or <italic>I</italic><sup>2</sup>&gt;50%, a random effects model would be used.ResultsA total of 10 RCTs with 736 patients were included, with 368 cases in the control group and the experimental group respectively. Meta-analysis results showed that, (1) The spasticity improvement rate: compared with the control group, the effective rate of the experimental group was significantly higher [<italic>OR</italic>=3.96, 95% <italic>CI</italic> (1.25,12.53), <italic>Z</italic>=2.34, <italic>P</italic>=0.02]. (2) MAS grade: compared with the control group, the grade of spasticity of the experimental group was significantly lower [<italic>RR</italic>=3.03, 95% <italic>CI</italic> (2.08, 4.41), <italic>Z</italic>=5.78, <italic>P</italic>&lt;0.000 01]. (3) CSI score: compared with the control group, CSI score of the experimental group was significantly lower [<italic>MD</italic>= -0.96, 95% <italic>CI</italic> (-1.26, -0.66), <italic>Z</italic>=6.20, <italic>P</italic>&lt;0.000 01]. (4) FMA score: compared with the control group, FMA score of the experimental group was significantly higher [<italic>MD</italic>=15.17, 95% <italic>CI</italic> (7.89, 22.46), <italic>Z</italic>=4.08, <italic>P</italic>&lt;0.000 1]. (5) BI score: compared with the control group, BI score of the experimental group was significantly higher [<italic>MD</italic>=5.95, 95% <italic>CI</italic> (4.38, 7.53), <italic>Z</italic>=7.39, <italic>P</italic>&lt;0.000 01].ConclusionMoxibustion with seed-sized moxa-cone at Jing acupoint can effectively improve the spasticity of limbs, reduce muscle tone, improve the motor function of limbs and quality of life of patients after stroke. However, more studies and samples would be needed for further validation in order to provide more reliable clinical evidence, due to the limitations of the included literature.http://kfxb.publish.founderss.cn/thesisDetails#10.3724/SP.J.1329.2023.04011strokehemiplegiaspasmsmotor functionJing acupointmoxibustion with seed-sized moxa-coneMeta-analysis
spellingShingle ZHANG Jinfei
JIANG Jiahui
TANG Jiqin
Therapeutic Efficacy of Moxibustion with Seed-Sized Moxa-Cone at Jing Acupoint on Limb Spasticity after Stroke: A Meta-Analysis
康复学报
stroke
hemiplegia
spasms
motor function
Jing acupoint
moxibustion with seed-sized moxa-cone
Meta-analysis
title Therapeutic Efficacy of Moxibustion with Seed-Sized Moxa-Cone at Jing Acupoint on Limb Spasticity after Stroke: A Meta-Analysis
title_full Therapeutic Efficacy of Moxibustion with Seed-Sized Moxa-Cone at Jing Acupoint on Limb Spasticity after Stroke: A Meta-Analysis
title_fullStr Therapeutic Efficacy of Moxibustion with Seed-Sized Moxa-Cone at Jing Acupoint on Limb Spasticity after Stroke: A Meta-Analysis
title_full_unstemmed Therapeutic Efficacy of Moxibustion with Seed-Sized Moxa-Cone at Jing Acupoint on Limb Spasticity after Stroke: A Meta-Analysis
title_short Therapeutic Efficacy of Moxibustion with Seed-Sized Moxa-Cone at Jing Acupoint on Limb Spasticity after Stroke: A Meta-Analysis
title_sort therapeutic efficacy of moxibustion with seed sized moxa cone at jing acupoint on limb spasticity after stroke a meta analysis
topic stroke
hemiplegia
spasms
motor function
Jing acupoint
moxibustion with seed-sized moxa-cone
Meta-analysis
url http://kfxb.publish.founderss.cn/thesisDetails#10.3724/SP.J.1329.2023.04011
work_keys_str_mv AT zhangjinfei therapeuticefficacyofmoxibustionwithseedsizedmoxaconeatjingacupointonlimbspasticityafterstrokeametaanalysis
AT jiangjiahui therapeuticefficacyofmoxibustionwithseedsizedmoxaconeatjingacupointonlimbspasticityafterstrokeametaanalysis
AT tangjiqin therapeuticefficacyofmoxibustionwithseedsizedmoxaconeatjingacupointonlimbspasticityafterstrokeametaanalysis